| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | 0.019 | 0.9 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | 0.024 | 0.9 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.025 | 0.9 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.9 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.0042 | 0.9 |